Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: A Southwest Oncology Group study (S0012)

Breast Cancer Research and Treatment

Volumn 119, Issue 2, 2010, Pages 391-398

  Slovak, Marilyn L ^a,j   Bedell, Victoria ^a   Lew, Danika ^b   Albain, Kathy S ^c   Ellis, Georgiana K ^d   Livingston, Robert B ^e   Martino, Silvana ^f   Perez, Edith A ^g   Hortobagyi, Gabriel N ^h   Sher, Dorie ⁱ   Stock, Wendy ⁱ  

^a City of Hope ^*  (United States)

^b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f Angeles Clinic and Research Institute   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j PerkinElmer   (United States)

more..

Author keywords

Breast cancer; Clonal hematopoiesis; HUMARA; MSI; T MN

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; AGED; ARTICLE; BONE MARROW TUMOR; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CLONAL VARIATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; FOLLOW UP; GENETIC DAMAGE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HETEROZYGOSITY LOSS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; MICROSATELLITE INSTABILITY; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 75049085476     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0597-5     Document Type: Article

References (35)

1. Vardiman JW, Arber DA, Brunning RD et al (2008) Therapy-related myeloid neoplasm. In: Swerdlow SH, Campo E, Harris NL et al (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissue. IARC, Lyon
2. M Crump D Tu L Shepherd M Levine V Bramwell K Pritchard 2003 Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 1 16 3066 3071 10.1200/JCO.2003.08.137 10.1200/JCO.2003.08.137 (Pubitemid 46606286)
3. D Hershman AI Neugut JS Jacobson, et al. 2007 Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy J Natl Cancer Inst 99 3 196 205 10.1093/jnci/djk028 10.1093/jnci/djk028 1:CAS:528:DC%2BD2sXis1Shtbg%3D 17284714
4. MC Le Deley F Suzan B Cutuli, et al. 2007 Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer J Clin Oncol 25 3 292 300 10.1200/JCO.2006.05.9048 10.1200/JCO.2006.05.9048 1:CAS:528: DC%2BD2sXitFSjtbc%3D 17159192 (Pubitemid 350003017)
5. G Leone L Pagano D Ben-Yehuda MT Voso 2007 Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica 92 10 1389 1398 10.3324/haematol.11034 10.3324/haematol.11034 1:CAS:528:DC%2BD2sXht12rurjN 17768113 (Pubitemid 350144157)
6. C Praga J Bergh J Bliss, et al. 2005 Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide J Clin Oncol 23 18 4179 4191 10.1200/JCO.2005.05.029 10.1200/JCO.2005.05.029 1:CAS:528:DC%2BD2MXmt1els7s%3D 15961765 (Pubitemid 46211324)
7. RE Smith J Bryant A DeCillis S Anderson 2003 Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience J Clin Oncol 21 7 1195 1204 10.1200/JCO.2003.114 10.1200/JCO.2003.03.114 1:CAS:528:DC%2BD2cXpsVWqsL4%3D 12663705
8. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140.6736(05)66544-0 10.1016/S0140-6736(05)66544-0
9. Mariotto AB, Feuer EJ, Harlan LC, Abrams J (2006) Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr (36):7-15. doi: 10.1093/jncimonographs/lgj0003
10. M Trudeau F Charbonneau K Gelmon, et al. 2005 Selection of adjuvant chemotherapy for treatment of node-positive breast cancer Lancet Oncol 6 11 886 898 10.1016/S1470-2045(05)70424-1 10.1016/S1470-2045(05)70424-1 1:CAS:528:DC%2BD2MXhtFOmsb%2FI 16257797 (Pubitemid 41614801)
11. A Jacobs 1991 Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia Leukemia 5 4 277 282 1:STN:280:DyaK3M3is1aiuw%3D%3D 2027296
12. G Abrahamson NJ Fraser J Boyd I Craig JS Wainscoat 1990 A highly informative X-chromosome probe, M27 beta, can be used for the determination of tumour clonality Br J Haematol 74 3 371 372 10.1111/j.1365-2141.1990.tb02601.x 10.1111/j.1365-2141.1990.tb02601.x 1:STN:280:DyaK3c3ktFyjtA%3D%3D 2334646
13. G Carter DC Hughes RE Clark, et al. 1990 RAS mutations in patients following cytotoxic therapy for lymphoma Oncogene 5 3 411 416 1:STN:280:DyaK3c7ptFOhug%3D%3D 2179819
14. S Mach-Pascual RD Legare D Lu, et al. 1998 Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study Blood 91 12 4496 4503 0006-4971/98/9112-0011$3.00/0 1:CAS:528:DyaK1cXjvVGhtr8%3D 9616144
15. RE Gale C Bunch DJ Moir KG Patterson AH Goldstone DC Linch 1996 Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns Br J Haematol 93 1 53 58 10.1046/j.1365-2141.1996.4751014.x 10.1046/j.1365-2141.1996. 4751014.x 1:STN:280:DyaK283gtVCgsA%3D%3D 8611475 (Pubitemid 26132388)
16. RC Allen HY Zoghbi AB Moseley HM Rosenblatt JW Belmont 1992 Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation Am J Hum Genet 51 6 1229 1239 1:CAS:528:DyaK3sXhvV2htL4%3D 1281384
17. E Delabesse S Aral P Kamoun B Varet AG Turhan 1995 Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene Leukemia 9 9 1578 1582 1:STN:280:DyaK2MzoslKksQ%3D%3D 7658727
18. RE Gale CA Mein DC Linch 1996 Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay Leukemia 10 2 362 367 1:STN:280:DyaK283gtVWmsw%3D%3D 8637249
19. T Bocker J Diermann W Friedl, et al. 1997 Microsatellite instability analysis: a multicenter study for reliability and quality control Cancer Res 57 21 4739 4743 1:CAS:528:DyaK2sXnt12gurk%3D 9354434
20. F Canzian R Salovaara A Hemminki, et al. 1996 Semiautomated assessment of loss of heterozygosity and replication error in tumors Cancer Res 56 14 3331 3337 1:CAS:528:DyaK28Xktlaqt7k%3D 8764130
21. A Edwards HA Hammond L Jin CT Caskey R Chakraborty 1992 Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups Genomics 12 2 241 253 0888-7543/923.00 10.1016/0888-7543(92)90371-X 1:CAS:528:DyaK38XktVajsLg%3D 1740333
22. MF Fey 1997 Microsatellite markers in leukaemia and lymphoma: comments on a timely topic Leuk Lymphoma 28 1-2 11 22 10.3109/10428199709058325 1:CAS:528:DC%2BD3cXis1ars7o%3D 9498699
23. JM Hoang PH Cottu B Thuille RJ Salmon G Thomas R Hamelin 1997 BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines Cancer Res 57 2 300 303 1:CAS:528:DyaK2sXntFKhtw%3D%3D 9000572
24. XP Zhou JM Hoang P Cottu G Thomas R Hamelin 1997 Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors Oncogene 15 14 1713 1718 10.1038/sj.onc.1201337 1:CAS:528:DyaK2sXmslClu7k%3D 9349505
25. RE Gale H Wheadon P Boulos DC Linch 1994 Tissue specificity of X-chromosome inactivation patterns Blood 83 10 2899 2905 1:CAS:528: DyaK2cXkvVShtbc%3D 8180385
26. GL Chen JT Prchal 2007 X-linked clonality testing: interpretation and limitations Blood 110 5 1411 1419 10.1182/blood-2006-09-018655 10.1182/blood-2006-09-018655 1:CAS:528:DC%2BD2sXhtVSgsb%2FN 17435115 (Pubitemid 47443955)
27. L Busque R Mio J Mattioli, et al. 1996 Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age Blood 88 1 59 65 1:CAS:528:DyaK28XjvFSnsLk%3D 8704202
28. L Tonon G Bergamaschi C Dellavecchia, et al. 1998 Unbalanced X-chromosome inactivation in haemopoietic cells from normal women Br J Haematol 102 4 996 1003 10.1046/j.1365-2141.1998.00863.x 10.1046/j.1365-2141.1998.00867.x 1:STN:280:DyaK1cvgtlOiuw%3D%3D 9734650 (Pubitemid 28410530)
29. M Boudewijns JJ van Dongen AW Langerak 2007 The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations J Mol Diagn 9 3 337 344 10.2353/jmoldx.2007.060155 10.2353/jmoldx.2007.060155 1:CAS:528:DC%2BD2sXot1Kqsrs%3D 17591933 (Pubitemid 47305070)
30. RE Smith 2003 Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience Clin Breast Cancer 4 4 273 279 10.3816/CBC.2003.n.032 1:CAS:528:DC%2BD3sXpvF2gtLg%3D 14651772
31. DA Patt Z Duan S Fang GN Hortobagyi SH Giordano 2007 Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk J Clin Oncol 25 25 3871 3876 10.1200/JCO.2007.12.0832 10.1200/JCO.2007.12.0832 17664457 (Pubitemid 47477263)
32. DJ Rossi D Bryder J Seita A Nussenzweig J Hoeijmakers IL Weissman 2007 Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age Nature 447 7145 725 729 10.1038/nature05862 10.1038/nature05862 1:CAS:528:DC%2BD2sXmtFelsrk%3D 17554309 (Pubitemid 46889729)
33. SM Chambers CA Shaw C Gatza CJ Fisk LA Donehower MA Goodell 2007 Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation PLoS Biol 5 8 e201 10.1371/journal.pbio.0050201 10.1371/journal.pbio.0050201 17676974 (Pubitemid 47328278)
34. JK Choi SC Kim 2007 Environmental effects on gene expression phenotype have regional biases in the human genome Genetics 175 4 1607 1613 10.1534/genetics.106.069047 10.1534/genetics.106.069047 1:CAS:528: DC%2BD2sXmsFymtb4%3D 17237506 (Pubitemid 46789948)
35. L Busque Y Paquette S Provost DC Roy RL Levine L Mollica DG Gilliland 2009 Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies Blood 113 15 3472 3474 10.1182/blood-2008-12- 195677 10.1182/blood-2008-12-195677 1:CAS:528:DC%2BD1MXkslCku74%3D 19202126